Week 3 Flashcards

1
Q

what is Atherosclerosis

A

a disease where plaque, composed of fat, cholesterol, and other substances, builds up inside the arteries, causing them to narrow and potentially block blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aetiology of Atherosclerosis

A

Risk factors – non modifiable
- Familial hypercholesterolaemia
- Age and gender
- Type 1 diabetes mellitus
Risk factors – modifiable
- HDL cholesterol <40 mg/dL
- C-reactive Protein levels (CRP)
- High homocysteine levels
___________________________________
- retention of LDL particles by macrophages within the arterial wall leads to oxidation and generation of an inflammatory milieu, relstuing in accumulation of foam cells, fatty streaks and plaque

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathogenesis of Atherosclerosis

A

Formation of fibrofatty leisons in the intimal lining
fatty streaks
Fibrous atheromatous plaque
Complicated lesion

  1. Endothelium dysfunction
    - Active biologic interface between blood and tissues
    - Risk factors effect
    - Dysfunction due to loss of NO and microtears
    - Leukocytes recruited and inflammatory process starts
  2. Endothelium inflammation
    - Entry of circulating fat and cholesterol
    - Oxidisation of LDLs
    - Attracts circulating monocytes (become macrophages) to restore vessel wall integrity
    - Inflammatory mediators released
    - Smooth muscle cells grow and enter
    - Macrophages and migrating smooth muscle cells consume ox-LDLs (foam cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epidemiology of atherosclerosis

A
  • Begin in childhood with the development of fatty streaks
  • The lesions of atherosclerosis advance with aging
  • Dyslipidaemia includes, but is not limited to, patients with abnormal levels of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol and triglycerides
  • In 2022, approximately 8.4% of Australians (2.1 million people) reported having high cholesterol, an increase from 6.8% in 2011–12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical manifestations of Atherosclerosis

A

stroke, TIA, acute coronary syndromes, stable angina, silent ischaemia, aortic dissection, aortic aneurysms,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

progression of Atherosclerosis

A
  1. Endothelial Dysfunction and Inflammatory Cell Recruitment
    - Atherosclerosis begins with endothelial injury triggered by LDL-cholesterol accumulation and other risk factors. This damage leads to the activation of endothelial cells, which upregulate adhesion molecules (ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule-1) on the image)
    - These molecules recruit circulating monocytes and lymphocytes to the site of injury. On adherence, monocytes migrate into the arterial intima where they differentiate into macrophages and initiate an inflammatory cascade. The endothelial dysfunction also impairs nitric oxide (NO) production, which normally maintains vascular homeostasis and prevents excessive immune cell adhesion
  2. Foam Cell Formation: The Inflammatory Amplification Cycle
    - Inside the arterial wall, macrophages engulf oxidised LDL (oxLDL), forming foam cells which amplifies inflammation through the release of pro-inflammatory cytokines. Additional immune cells are recruited, sustaining a chronic inflammatory loop that promotes plaque expansion. The inflammatory environment also impairs the clearance of apoptotic foam cells (a process known as efferocytosis), leading to the formation of a necrotic core rich in cellular debris and oxLDLs
  3. Plaque Progression and Fibrous Cap Formation
    - As the inflammatory response persists, smooth muscle cells (SMCs) migrate from the medial layer of the artery to the intima, where they proliferate and produce extracellular matrix (ECM) components such as collagen and elastin. This forms the fibrous cap, which serves as a protective barrier between the necrotic core and the bloodstream. However, chronic inflammation weakens this protective layer and leads to destabilisation of plaques, making them prone to rupture
  4. Plaque Rupture
    - A thin fibrous cap (<65 μm) over a large necrotic core with high macrophage density is considered a hallmark of a vulnerable plaque. As inflammation erodes the fibrous cap, it eventually ruptures, exposing the lipid core to circulating blood. This triggers platelet activation and the coagulation cascade, leading to the formation of a luminal thrombus. Depending on the severity and location of the thrombosis, this can result in an MI, ischaemic stroke or a peripheral arterial occlusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Vascular aging

A
  • Major risk factor for CVD
  • Involves the deterioration in arterial structure and function over time, which ultimately leads to damage of heart, brain, kidney and other organs
    Key contributors of VA:
  • Increased arterial stiffness
  • Intimal thickening
  • Chronic pro-inflammatory conditions
  • Endothelial dysfunction
  • Increased atherogenic conditions and formation of unstable plaque
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Structural and functional changes for VA

A
  1. Arteriosclerosis – stiffening of the arterial wall
    Aging has been demonstrated to lead to increased arterial stiffness by affecting the factors that are key in maintaining arterial compliance
    These include:
    - Elastin fibres which are broken down by enzymes (e.g., matrix metalloproteinases). The elastin is progressively replaced with stiffer collagen fibres, leading to reduced compliance
    - Changes to vascular smooth muscle cells with age. They shift from maintaining normal function to promoting fibrosis and calcification; they also proliferate and produce more extracellular matrix, thickening tunica media
    - Increase in advanced glycation end-products (AGEs), a heterogeneous group of compounds that form when proteins, lipids or nucleic acids become non-enzymatically glycated and oxidised. They cause damage by cross-linking proteins like collagen and elastin, leading to arterial stiffening, activating pro-inflammatory and oxidative pathways, damage endothelial cells, reduce nitric oxide (NO) bioavailability, and increase vascular calcification. They are endogenous (formed naturally in the body, especially in diabetics and ageing individuals) or exogenous (from diet and environment)
  2. Atherosclerosis – plaque formation and arterial narrowing
    - Affects intima layer, where lipids, immune and inflammatory cells, smooth muscle cells and connective tissue accumulate
    - Plaques progressively narrow arteries, potentially leading to thrombosis and obstruction.
    - Early-stage plaques are not necessarily stiff, but mature calcified plaques increase arterial stiffness
    A relationship between arteriosclerosis and atherosclerosis exists in that the increased arterial stiffness contributes to progression of atherosclerosis (e.g. due to hypertension/endothelial injury) which in turn increases stiffness of vessel walls as the arteries narrow and calcify.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peipheral artery disease (PAD) what is it

A

a condition where narrowed arteries reduce blood flow to the legs and feet, often causing pain, numbness, or coldness, and can lead to serious complications if left untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PAD Aetiology

A
  • Arterial occlusions are usually from a thrombus
  • The initiating event is a pre-existing history of PAD
  • Thrombotic occlusions can occur in an upper and lower extremities segment but most commonly affect the superficial femoral artery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PAD Epidemiology

A

UNKNOWN
- est affect 20% of 75yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PAD Pathophysiology

A
  • athlerosclerosis
  • infection or inflammation
  • ## acute thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vasculitis

A

a group of disorders characterized by inflammation of blood vessels, which can lead to narrowing, weakening, or scarring of the vessels, potentially restricting blood flow and damaging organs or tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vasculitis Aetiology

A

UNKNOWN
- inflammatory process
- in conjunction with other illnesses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pathogenesis of Vasculitis

A
  • Acute or chronic inflammation of blood vessels
  • Vessels vary in size, type, and location
  • Vessel changes
  • Presence of leukocytes
  • Can be serious/fatal
  • Prompt recognition and therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical manifestations of vasculitis

A
  • Fever
  • Night sweats
  • Malaise
  • Myalgia
  • Arthralgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

large vessel vasculitis types

A
  • Giant cells arteritis
  • Takayasu arteries
  • Aortitis in Cogan’s syndrome
  • Aortitis in spondyloarthropathies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

giant cell arteritis

A
  • Thoracic aorta – carotid arteries
  • Small extracranial branches of carotid arteries
  • Older adults (50-60yo)
  • Clinical manifestations – headache, visual disturbances, jaw pain, gradual
  • Progress to stroke, vascular stenosis, aneurysm or dilation, dissection or rupture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Takayasu arteritis

A
  • Epidemiology: women>men, 20-30yo
  • Pathophysiology: inflammation and thickening of aorta and great arteries + lumen narrowing
  • Clinical manifestations: unequal blood pressure, absent arm pulses, claudication of arm, cerebral symptoms
  • MRI and angiography, blood tests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Medium vessel vasculitis

A
  • Aetiology: unknown
  • Epidemiology: children 6 months – 5yo; males
  • 200-300 cases/year
  • Similar response to COVID-19
  • Multisystem inflammatory syndrome in children
  • Paediatric inflammatory multisystemic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Polyarteritis Nodosa what is it

A

a rare disease that causes inflammation and damage to the medium-sized blood vessels in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Polyarteritis Nodosa Aetiology

A
  • Idiopathic
  • Hep B/C virus, leukaemia
  • Allergic reaction to drugs and vaccines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Polyarteritis Nodosa Epidemiology

A
  • Men>women
  • 45-60yo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Polyarteritis Nodosa clinical manifestations

A
  • Fatigue, loss of appetite, abdominal pain, HTN, chest pain, difficulty breathing
  • Numbness tingling/loss of strength in hands and feet
  • GIT – bleeding or perforation
  • Heart – angina or myocardial infraction
  • Kidneys – cortical infracts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
small vessel vasculitis what is it
a condition where the smallest blood vessels (arterioles, capillaries, and venules) become inflamed, potentially causing damage to tissues and organs TYPES: Cutaneous small vessel vascultiis eosinophilic granulomatosis with polyangiitis
26
Cutaneous small vessel vasculitis Aetiology Clinical manifestations
- Cutaneous small vessel vasculitis - rash
27
Eosinophilic granulomatosis with polyangiitis Aetiology Clinical manifestations
- Reaction, infection, environmental - Rhinosinusitis, asthma, peripheral blood eosinophilia, peripheral neuropathy
28
Cryoglobulinemia what is it
a condition where abnormal proteins called cryoglobulins are present in the blood, and these proteins precipitate or clump together at low temperatures
29
Cryoglobulinemia aetiology epidemiology, pathogenesis, clinical man
1, Unknown 2, Chronic infection/inflammation 3, Abnormal blood proteins clump together 4, Purpura, arthralgia and weakness
30
Arterial Obstruction
a condition where blood flow through an artery is either partially or completely blocked
31
Arterial Obstruction Aetiology
- Thrombosis, atherosclerotic plaque, latrogenic, traumatic, arterial embolism
32
Arterial Obstruction Pathogenesis
- Associated with atherosclerosis and diabetes - Vasospasm, venous insufficiency, embolism and vasculitis
33
Arterial Obstruction clinical man
- Reduced perfusion in peripheral tissues – ischemia and tissue necrosis - Depends upon aetiology and if has underlying peripheral artery disease - Critical limb ischemia - Six Ps of acute ischemia: pain, pallor, poikilothermic, pulselessness, paraesthesia and paralysis
34
Arterial Obstruction why does it occur
When an artery becomes blocked, tissues downstream lose their oxygen and nutrient supply. Since oxygen is essential for aerobic metabolism, cells must switch to anaerobic metabolism to generate energy. This shift leads to a cascade of harmful biochemical and cellular changes, ultimately resulting in cell death (necrosis)
35
Arterial Obstruction 3 issues unfold
1. Anaerobic Metabolism and Acidosi Lactic acid accumulation → Tissue acidosis (↓ pH), which; - Disrupts enzyme function - Damages proteins and cell membranes = Leads to oxidative stress and free radical formation Why is this bad? Acidosis worsens cellular dysfunction and contributes to tissue injury 2. ATP Depletion and Ion Pump Failure ATP is needed for ion pumps to maintain cell homeostasis. When ATP is depleted, two critical pumps fail:  Sodium-Potassium (Na⁺/K⁺) Pump Failure: normally, pumps Na⁺ out and K⁺ in to maintain resting potential but failure leads to Na⁺ accumulation inside cells, causing water influx and cell swelling (cellular oedema)  Calcium (Ca²⁺) Pump Failure: normally, keeps Ca²⁺ out of the cytoplasm to prevent enzyme activation but failure leads to Ca²⁺ overload, triggering harmful enzymatic activity inside the cell Why is this bad? Swollen cells disrupt tissue structure and function Excess Ca²⁺ activates destructive enzymes (phospholipases, proteases), which degrade vital cell components 3. Calcium Overload and Muscle Necrosis It leads to irreversible muscle fibre destruction, progressing to gangrene if untreated 4. Release of Cellular Contents into the Bloodstream As cells die, they rupture and release their internal contents into circulation, leading to systemic complications:
36
PAD clinical man
- Intermittent or irregular pain during activity and rest - Numbness, coldness or pins and needles in the affected body part - Blue- or purple-tinged skin - Sores or ulcers in the affected body part that do not heal - Blackened areas of skin or loss of skin (gangrene) - Intermittent or irregular pain during activity and rest - Numbness, coldness or pins and needles in the affected body part - Blue- or purple-tinged skin - Sores or ulcers in the affected body part that do not heal - Blackened areas of skin or loss of skin (gangrene)
37
Aneurysms what is it
= an enlargement of an artery resulting in a diameter of more than 1.5 times the normal size - True aneurysms have an intact arterial wall consisting of all three layers (intima, media and adventitia) and occur due to atherosclerosis or degeneration in the artery - False (pseudoaneurysms) lack a complete arterial wall and are related to trauma, iatrogenic injury or infection. - Aneurysms are defined by their location relative to the visceral vessels, involvement of the vessel layer walls, morphology (saccular versus fusiform), and diameter (small versus large
38
Aneurysms Aetiology
- An aneurysm is a localised dilation or bulging of a blood vessel due to weakening of the arterial wall - The development of aneurysms is influenced by a combination of genetic, degenerative, inflammatory and hemodynamic factors
39
Aneurysms Epidemiology
- In Australia, the prevalence and incidence of aneurysms vary based on type, age, sex, and ethnicity. - It is estimated that 2–3% of the adult population may develop an aneurysm over their lifetime, though many remain asymptomatic and undetected - Congenital Factors: Connective tissue disorders (e.g., Marfan syndrome, Ehlers-Danlos syndrome) - Degenerative Changes: Atherosclerosis (causing weakening of arterial wall); hypertension (increases mechanical stress on vessel walls); aging (reduces elasticity and integrity of vessel) - Inflammatory and Infectious Causes: Vasculitis (e.g., Takayasu arteritis, Giant cell arteritis); autoimmune disorders and infections (due to bacterial or fungal infections e.g., tuberculosis) - Trauma and Iatrogenic Causes: Blunt or penetrating trauma; surgical or endovascular interventions (e.g., coronary angiogram) leading to pseudoaneurysm formation - Lifestyle and Environmental Factors: Tobacco smoking (promotes oxidative stress and vascular damage); dyslipidaemia (contributes to atherosclerosis) and other risk factors linked to development of atherosclerosis and hypertension such as diet, being sedentary and the environment (e.g., air pollution and heatwaves)
40
Aneurysms clinical man
- Depend on size and location, may be asymptomatic - Brain: asymptomatic unless it ruptures - Thoracic: substernal, back and neck pain, dyspnoea, stridor, brassy cough - Abdominal: pulsating mass, mild-severe mid-abdominal or lumbar discomfort to severe abdominal or back pain
41
venous disorders aetiology
- Asymptomatic or symptomatic
42
Venous Disorders Pathogenesis
- Inadequate muscle pump function - Incompetent valves (reflux) - Venous thrombosis or non-thrombotic venous obstruction - Anatomic, physiologic and histologic changes leading to vein dilation, skin changes and/or skin ulceration
43
Varicose Veins what is it
- Superficial veins - Remodelling of vessel wall - Possible genetic link - More common in women > men
44
Varicose Veins clinical man
- Oedema, skin changes, venous ulceration - Chronic venous insufficiency - Superficial and/or deep venous reflex and/or obstruction
45
thrombosis what is it
The formation of a blood clot (thrombus) within a blood vessel, either an artery or a vein
46
Thrombophlebitis what is it
= refers to inflammation of a vein associated with thrombus (blood clot) formation - Thrombus in vein + inflammation - Superficial or deep veins - Secondary to other conditions
47
Thrombophlebitis Aetiology and Epidemiology
- VTE is associated with conditions that increase the risk of clotting, including those that lead to decreased venous flow and pooling, abnormalities of coagulation or fibrinolysis and endothelial dysfunction - Each year in Australia, about 1 in 1000 people develop a first episode of VTE, which approximates to about 20,000 cases - More than half of these episodes occur during or soon after a hospital admission, which makes them potentially preventable
48
Thrombophlebitis clinical man
- Asymptomatic until clot moves to another organ – lungs - Signs and symptoms are related to inflammation  Pain, swelling, deep muscle tenderness  Fever, malaise, elevated WBC  Site of thrombosis determines symptoms
49
Phlebothrombosis
- Known as deep venous thrombosis (DVT) - If untreated can result in complications e.g., pulmonary emboli
50
what is chronic venous disease
improper functioning of the vein valves in the leg, causing swelling and skin changes
51
Chronic venous disease Aetiology
- Venous hypertension results from structural factors (e.g., venous obstruction, valvular dysfunction) and functional factors (e.g., obesity, heart failure, weak calf muscles - The risk factors for developing chronic venous disease include:  Advancing age, female sex, family history of venous disease, ligamentous laxity, prolonged standing, increased body mass index, smoking, lower extremity trauma, prior venous thrombosis (ie, post-thrombotic) and certain hereditary conditions. - Impaired venous return leads to persistent ambulatory venous pressures of 60–90 mmHg, causing venous dilation and progressive damage. A genetic predisposition is suspected, though no single gene has been identified
52
Chronic venous disease Epidemiology
- Chronic venous disease (CVD) is one of the most common vascular conditions, affecting up to 39% of the Australian population - The risk of chronic venous disease increases with age and has a 3 to 1 female predominance
53
Chronic venous disease clinical man
Symptoms include: - Pain, leg heaviness, aching, swelling, skin dryness, tightness, itching, irritation, and muscle cramps - Venous claudication - a severe deep pain and tightness typically in the thigh muscles with vigorous exercise, can occur in the setting of acute, severe venous obstruction or longstanding venous obstruction Signs include: - Dilated veins (e.g., varicose veins - subcutaneous dilated, tortuous veins >3mm in diameter); chronic venous insufficiency is an advanced stage of CVD and is associated with oedema, skin changes and/or venous ulcers
53
Chronic venous disease pathogenesis
Anatomic changes: - Valvular incompetence causes venous reflux and dilation, creating a vicious cycle of vessel wall distortion and worsening valve failure - Chronic venous obstruction can lead to fibrosis and post-thrombotic syndrome Physiologic changes: - Normally, precapillary arterioles constrict upon standing to protect the capillary bed - In venous hypertension, this reflex is lost, allowing direct transmission of high venous pressure - Reduced shear stress triggers endothelial dysfunction, inflammation, and vessel wall remodelling, leading to venous insufficiency
54
Aortic Aneurysms what is it
a bulge in the wall of the aorta, the body's main artery, caused by weakening of the artery wall
55
Thoracic Aortic Aneurysm (TAA):
- Occurs in the upper part of the aorta - The majority (~95%) of patients are asymptomatic until a serious event, such as aortic dissection or rupture, occurs - This makes it difficult to determine the true prevalence of TAAs - However, estimates suggest an incidence of 5–10 cases per 100,000 person-years, with numbers increasing due to both population aging and improved detection - TAAs are more common in men - However, possibly due to decline in oestrogen levels during menopause, which may reduce the protective effects of oestrogen on the aortic wall, women over the age of 50 have a faster aneurysm progression
56
Abdominal Aortic Aneurysm (TAA)
- Defined as a localised enlargement of the abdominal aorta to a diameter of ≥30 mm (on abdominal US or CT) and are a degenerative disease of ageing - Approximately 4–7% of men and 1–2% of women over the age of 65 are affected
57
pathogenesis of Aortic Aneurysm
- In an aortic aneurysm, this normal architecture becomes compromised, leading to progressive weakening and dilation - The key initiating event is often the dysfunction and loss of vascular smooth muscle cells (VSMC), which are responsible for maintaining the extracellular matrix (ECM) and regulating vascular tone - As these cells become dysfunctional and die off, the ability of the aortic wall to repair itself diminishes, increasing its susceptibility to progressive dilation and rupture The process is complex: - At the core of aneurysm formation is VSMC dysfunction - they lose their contractile properties and undergo programmed cell death, reducing the strength of the aortic wall. This dysfunction occurs in response to chronic inflammation, oxidative stress and mechanical strain, and the VSMC start producing matrix metalloproteinases (MMPs), cytokines, and reactive oxygen species (ROS). - The ECM is crucial for maintaining the strength and elasticity of the aortic wall. It consists of elastin, which allows the aorta to stretch and recoil, and collagen, which provides tensile strength. In an aneurysm, these proteins undergo excessive degradation due to the overactivity of the MMPs, which break down the elastin and collagen, leading to loss of structural support and an increase in aortic wall compliance Chronic inflammation - Originates from chronic damage to the aortic wall, primarily due to high blood pressure, oxidative stress and atherosclerosis leading to small injuries in the vessel wall. These injuries trigger an immune response, where macrophages, T cells, and neutrophils infiltrate the aortic tissue to repair the damage. However, instead of resolving the injury, these immune cells prolong inflammation by releasing cytokines and enzymes (MMPs) that degrade elastin and collagen, and over time, this weakens the aortic wall, making it more susceptible to dilation and rupture Oxidative stress - From e.g., endogenous - aging, metabolic disorders, diabetes; exogenous - tobacco smoking, pollution, poor diet) further fuels this process by producing free radicals (ROS) that damage smooth muscle cells (VSMCs) and extracellular matrix (ECM) proteins. Normally, VSMCs help repair tissue damage, but in aneurysms, they become dysfunctional and fail to regenerate the damaged wall. This creates a cycle where the aortic wall continues to degrade, stimulating even more immune cell recruitment and inflammation Mechanical stress - The aorta is constantly under pressure from blood flow. In aneurysms, this stress is even higher than normal because the aortic wall is already weak. Hypertension and/or turbulent blood flow e.g., from atherosclerosis narrowing the arteries, cause tiny injuries and inflammation to the endothelial wall Chronic inflammation - Originates from chronic damage to the aortic wall, primarily due to high blood pressure, oxidative stress and atherosclerosis leading to small injuries in the vessel wall. These injuries trigger an immune response, where macrophages, T cells, and neutrophils infiltrate the aortic tissue to repair the damage. However, instead of resolving the injury, these immune cells prolong inflammation by releasing cytokines and enzymes (MMPs) that degrade elastin and collagen, and over time, this weakens the aortic wall, making it more susceptible to dilation and rupture Oxidative stress - From e.g., endogenous - aging, metabolic disorders, diabetes; exogenous - tobacco smoking, pollution, poor diet) further fuels this process by producing free radicals (ROS) that damage smooth muscle cells (VSMCs) and extracellular matrix (ECM) proteins. Normally, VSMCs help repair tissue damage, but in aneurysms, they become dysfunctional and fail to regenerate the damaged wall. This creates a cycle where the aortic wall continues to degrade, stimulating even more immune cell recruitment and inflammation Mechanical stress - The aorta is constantly under pressure from blood flow. In aneurysms, this stress is even higher than normal because the aortic wall is already weak. Hypertension and/or turbulent blood flow e.g., from atherosclerosis narrowing the arteries, cause tiny injuries and inflammation to the endothelial wall
58
cerebral aneurysms (CA) what is it
dilations that occur at weak points along the arterial circulation within the brain
59
cerebral aneurysms (CA) epidemiology
- Global prevalence of cerebral aneurysms is approx. 3.2%, with a mean age of 50 and an overall 1:1 gender ratio - This ratio changes after age 50, with an increasing female predominance approaching 2:1. CAs can vary in size (small < 0.5 mm, large>25 mm), are saccular (berry) and asymptomatic
60
cerebral aneurysms (CA) pathogenesis
- CAs most frequently develop in areas where blood flow causes high wall shear stress, which is why they commonly occur at vessel bifurcations - In cerebral aneurysms, VSMCs produce pro-inflammatory molecules that lead to localised weakening, rather than widespread wall loss as seen in aortic aneurysms - Whereas AAAs are driven by chronic inflammation, CAs have increased endothelial dysfunction and local cytokine activation - Whereby AAA expands progressively over time, CAs rupture unpredictably, even at smaller sizes, due to localised weakening at high-flow bifurcations
61
peripheral Aneurysms what is it
- Aneurysms occurring in the arteries of the lower limb are the most common peripheral aneurysms -
62
peripheral Aneurysms Pathogenesis
- They share common mechanisms with aortic aneurysms, including inflammation, ECM degradation and haemodynamic stress, but they also have unique contributors such as higher atherosclerotic involvement, localised mechanical stress, and genetic predisposition - Peripheral arteries experience more shear stress and turbulent blood flow in areas of arterial branching (such as the popliteal artery) which contribute to localised wall weakening and aneurysm formation
63
Clinical manifestations for peripheral, cerebral and aortic aneurysms
- The clinical presentations of aneurysms depend on their location, size, and whether they have ruptured - Aneurysms in different locations manifest differently but share common risks of rupture and ischaemic complications - Aortic aneurysms are often silent until rupture, cerebral aneurysms present catastrophically with SAH, and peripheral aneurysms are prone to embolism and limb ischemia
64
Hypertension what is it
high blood pressure, where blood pressure is permanently higher than normal
65
Hypertension readings
- Systolic blood pressure of 140 mmHg or more - Diastolic blood pressure of 90mmHg or more - Receiving medication for high blood pressure
66
Hypertension epidemiology
- 45% in 75 and older both female and male ' - higher rates in males - same for both lower and higher socio
67
pathophysiology of Hypertension
- Blood pressure reacts to changes in the environment to maintain organ perfusion over a wide variety of conditions - The primary factors determining the blood pressure are the sympathetic nervous system, the renin-angiotensin-aldosterone system (RAAS), and the plasma volume (largely mediated by the kidneys) - However, the pathophysiology of hypertension involves complex interactions between environmental and behavioural factors, genes, hormonal networks and multiple organ systems (renal, cardiovascular, and central nervous system), as indicated in the image below
68
what causes high BP
1. RENAL - Pressure natriuresis relationship and RAAS 2. Vascular mechanisms - small arteries remodelling and large 3. neural mechanisms - baroreceptor dysfunction, overactivation of SNS control centre 4. hormonal mechanisms - RAAS, aldosterone, ostreogen, testosterone
69
clinical man of hypertension
microvascular remodelling LVH Myocardial infraction CAD endothelial dysfunction arthlerosclerosis arterial stiffness microbleeds in brain
70
Primary Hypertension what is it
chronic elevation of BP with no identifiable cause - Dysfunction in RAAS, SNS and renal sodium balance leads to sustained BP elevation
71
Primary Hypertension epidemiology
- In AUS, more than 34% of adults have high BP and majority (90-95%) have primarily hypertension with a multifactorial gene-environment aetiology
72
Primary Hypertension Pathogenesis
Primary hypertension results from genetic and environmental factors affecting cardiovascular and renal function Key mechanisms include: - SNS overactivity: increased norepinephrine raises heart rate and vasoconstriction - RAAS dysregulation: Excess angiotensin II and aldosterone increase vascular resistance and fluid retention - Endothelial dysfunction: Reduced nitric oxide and increased oxidative stress promote vasoconstriction - Salt sensitivity leads to volume expansion and increased BP
73
Primary Hypertension risk factors
Non-modifiable: - Age: BP increases with arterial stiffening - Genetics: Family history contributes to 30% of BP variations - Race: Higher prevalence and severity - Reduced Nephron Number: Genetic and prenatal factors impact renal function Modifiable: - High sodium intake: Excess sodium retention raises BP - Obesity and metabolic syndrome: Insulin resistance leads to vascular dysfunction - Physical inactivity: Reduced vascular flexibility and SNS overactivity - Excess alcohol and smoking: Increases vasoconstriction and endothelial damage - Chronic stress and poor sleep: SNS hyperactivity raises BP - Social and environmental factors: Low socioeconomic status, pollution and stress contribute to hypertension
74
clinical man of Primary hypertension
Asymptomatic in early stages, or morning headaches, dizziness, fatigue and vision changes Advanced-Stage: target organ damage leads to: - Cardiovascular: Heart failure, myocardial infarction - Cerebrovascular: Stroke, vascular dementia - Renal: Chronic kidney disease, nephropathy - Ophthalmic: Hypertensive retinopathy, vision loss - Peripheral Arteries: Atherosclerosis, limb ischaemia
75
Secondary Hypertension what is it
Elevated blood pressure due to an identifiable underlying cause, only 10% of hypertension cases
76
Secondary Hypertension Aetiology
- A number of common and uncommon medical conditions may increase BP and lead to secondary hypertension - In many cases, these causes may coexist with risk factors for primary hypertension and are significant barriers to achieving adequate BP control
77
Secondary Hypertension renal causes
The kidneys play a key role in BP regulation through fluid balance and electrolyte homeostasis. 1. Chronic Kidney Disease (CKD): In renal parenchymal disease, damaged nephrons fail to effectively excrete sodium and water, leading to intravascular volume expansion and elevated BP. Additionally, the kidneys respond to impaired perfusion by inappropriately activating the RAAS which further raises BP by promoting vasoconstriction and sodium retention. Hypertension accelerates kidney damage, creating a vicious cycle that increases the risk of end-stage renal disease (ESRD). 2. Renovascular Hypertension: Narrowing of the renal arteries (stenosis) reduces blood flow to the kidneys, triggering excessive RAAS activation as a compensatory response. Angiotensin II, a potent vasoconstrictor, increases systemic vascular resistance, while aldosterone promotes sodium and water retention, elevating BP. Secondary hyperaldosteronism in renal artery stenosis exacerbates hypertension and volume overload. 3. Role of Fluid Balance in BP Control: In advanced CKD, BP regulation becomes highly dependent on intravascular volume. Excess fluid accumulation (volume overload) worsens hypertension and contributes to pulmonary congestion and heart failure. Diuretics and sodium restriction are essential in controlling BP in CKD patients
78
Secondary Hypertension endocrine causes
- Primary Hyperaldosteronism: Excess aldosterone secretion (usually from an adrenal adenoma or bilateral adrenal hyperplasia) leads to sodium retention, potassium excretion and volume expansion, causing hypertension. - Pheochromocytoma: A tumour of the adrenal medulla that secretes excess catecholamines (epinephrine and norepinephrine) which causes episodic or sustained hypertension by increasing heart rate and CO and constricting blood vessels, raising systemic vascular resistance - Cushing’s Syndrome: Excess cortisol increases BP via RAAS activation and vasoconstriction - Thyroid Disorders: Hypothyroidism and hyperthyroidism can both elevate BP via altered vascular resistance - Acromegaly: Excess growth hormone increases sodium retention and cardiac output
79
Secondary Hypertension other causes
Vascular Causes: Coarctation of Aorta: Congenital narrowing increases upper body BP while lowering lower limb BP Neurological Causes: Increased Intracranial Pressure e.g. from brain tumours, head trauma or hydrocephalus increases BP via the Cushing reflex Medication-Induced Hypertension: NSAIDs, corticosteroids, oral contraceptives, sympathomimetics and cyclosporine can elevate BP. Recreational Drugs (Cocaine, Amphetamines) can cause acute or chronic hypertension. Obstructive Sleep Apnea (OSA): Chronic hypoxia and SNS activation increase BP variability and risk of resistant hypertension Pregnancy-Related Hypertension: Preeclampsia and Eclampsia: Endothelial dysfunction, vasoconstriction, and fluid retention elevate BP
80
Hypotension what is it
decrease in systemic blood pressure below accepted low values, typically recognised as less than 90/60 mmHg - classified into different types, including absolute, relative, orthostatic, and profound hypotension
81
Hypotension aetiology
- Blood pressure regulation is primarily dependent on cardiac output and systemic vascular resistance - Any pathology affecting these factors can result in hypotension Cardiac output reduction: - Heart failure (systolic/diastolic dysfunction) - Arrhythmias (bradycardia, tachycardia) - Myocardial infarction - Valvular heart diseases - Cardiac tamponade Hypovolaemia: - Haemorrhage - Dehydration (vomiting, diarrhoea, excessive diuresis) - Adrenal insufficiency (e.g., Addison’s disease) Decreased systemic vascular resistance: - Septic shock (due to bacterial endotoxins) - Anaphylactic shock (severe allergic reaction) - Neurogenic shock (spinal cord injury) - Certain medications (vasodilators, beta-blockers, calcium channel blockers) Endocrine disorders: - Hypothyroidism (leading to reduced cardiac contractility) - Adrenal insufficiency (loss of vasopressor effects of cortisol) Neurological disorders: - Autonomic dysfunction (Parkinson’s disease, Dementia with Lewy bodies; diabetic neuropathy which affects peripheral nerves; older age as these decreases in baroreceptor sensitivity) - Prolonged bed rest (deconditioning of baroreceptors)
82
Hypotension pathogenesis
Hypotension results from the disruption of one or more of the following physiological mechanisms: Decreased cardiac output: - CO is the product of stroke volume (amount of blood ejected per heartbeat) and heart rate. Any condition that impairs myocardial contractility, reduces preload (blood returning to the heart), or affects heart rate can lead to reduced CO and hypotension - Conditions include heart failure, myocardial infarction, severe bradycardia and cardiac tamponade Reduced systemic vascular resistance (SVR): - Blood pressure is determined by the diameter of blood vessels. Vasodilation decreases SVR, leading to a drop in BP - This is seen in distributive shock (septic, anaphylactic or neurogenic shock), where excessive vasodilation occurs due to the release of inflammatory mediators or autonomic dysfunction Impaired baroreceptor reflex: - Baroreceptors in the carotid sinus and aortic arch sense changes in BP and trigger compensatory mechanisms via the autonomic nervous system. In normal physiology, a drop in BP triggers sympathetic activation, increasing heart rate and vasoconstriction - Conditions such as autonomic neuropathy, prolonged bed rest or neurodegenerative diseases impair this reflex, resulting in orthostatic hypotension Fluid and electrolyte imbalance: - Hypovolaemia due to dehydration, haemorrhage or excessive diuresis reduces intravascular volume, decreasing stroke volume and CO - Electrolyte imbalances, such as hyponatraemia or adrenal insufficiency, can exacerbate hypotension by impairing fluid balance and vascular tone Endocrine dysregulation: - Adrenal insufficiency leads to decreased production of cortisol and aldosterone, impairing sodium retention and vascular tone regulation. - Hypothyroidism decreases cardiac contractility and heart rate, contributing to low blood pressure Medication effects: - Antihypertensives (beta-blockers, ACE inhibitors, diuretics) can cause excessive blood pressure reduction. - Vasodilators, sedatives, and anaesthetics can contribute to hypotension by decreasing vascular tone and myocardial contractility Autonomic nervous system dysfunction: - REVISION: Autonomic nervous system regulates BP through the balance between sympathetic and parasympathetic activity. Sympathetic activation increases HR and vascular resistance, raising BP. Parasympathetic activation lowers HR and dilates vessels, decreasing BP. - Dysfunction in autonomic regulation (e.g., diabetic autonomic neuropathy, Parkinson’s disease, spinal cord injury) results in inadequate BP compensation, leading to hypotension, particularly orthostatic hypotension
83
Hypotension clinical man
Symptoms depend on the severity and cause of hypotension General symptoms: - Dizziness, light-headedness - Fatigue - Blurred vision - Nausea - Syncope (fainting) Neurological symptoms (due to reduced cerebral perfusion) - Confusion, difficulty concentrating - Seizures in severe cases Sign of Shock - Cold - Clammy skin - Rapid pulse - Low urine output - Metabolic acidosis - Mutli organ failure in prolonged cases
84
Types of Hypotension
- Absolute Hypotension: Defined as a systolic BP lower than 90 mmHg or a mean arterial pressure (MAP) lower than 65 mmHg, indicating inadequate perfusion. - Relative Hypotension: A significant drop in BP from baseline despite being within normal ranges. This can occur in patients who usually have high blood pressure but experience a sudden reduction - Profound Hypotension: Medication-dependent or associated with life-threatening conditions requiring intensive management. - Shock (Severe Hypotension with Organ Hypoperfusion) - Orthostatic Hypotension: A decrease in systolic pressure of 20 mmHg or more, or diastolic pressure of 10 mmHg or more upon standing. This is commonly experienced in physiotherapy clinical practice, particularly among hospitalised patients, and among patients who are elderly, has diabetes and or are on antihypertensives, and caused by autonomic dysfunction, volume depletion or medications